← Patent-cliff monitor small molecule MYCAPSSA OCTREOTIDE ACETATE
Loss of exclusivity December 2040 latest FDA-listed patent expiry
Company CHIESI FARMACEUTICI SPA
Drug detail Brand name MYCAPSSA Active ingredient OCTREOTIDE ACETATE Strength EQ 20MG BASE Dosage form CAPSULE, DELAYED RELEASE Route ORAL Modality Small molecule FDA approval June 2020 Marketing status RX
Listed patents Patent Expires Type 11141457 December 2040 use U-3232 11890316 December 2040 use U-3232 12246054 February 2036 use U-2857 10695397 February 2036 use U-2857 10238709 February 2036 use U-2857 11510963 February 2036 use U-2857 11052126 February 2036 use U-2857 11857595 February 2036 use U-3784 11338011 February 2036 use U-2857 12251418 February 2036 use U-2857 8535695 September 2029 use U-2857 11986529 September 2029 use U-2857 11969471 September 2029 product 8329198 September 2029 product 9265812 September 2029 product 9566246 September 2029 product
Regulatory exclusivity Code Expires ODE-474 June 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.